QIAGEN NV's ticker is and the CUSIP is N72482AB3. A total of 8 filers reported holding QIAGEN NV in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,458,000 | +146.3% | 1,000,000 | +150.0% | 0.00% | 0.0% |
| Q1 2020 | $592,000 | -86.0% | 400,000 | -88.2% | 0.00% | -66.7% |
| Q4 2019 | $4,238,000 | -7.5% | 3,400,000 | -10.5% | 0.00% | -25.0% |
| Q3 2019 | $4,582,000 | +75.1% | 3,800,000 | +111.1% | 0.00% | +100.0% |
| Q2 2019 | $2,617,000 | – | 1,800,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXANE DERIVATIVES | 4 | $1,466,150,000 | 0.42% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,800,000 | $3,239,000 | 0.02% |
| AMUNDI ASSET MANAGEMENT US, INC. | 1,600,000 | $2,954,000 | 0.00% |
| BARCLAYS PLC | 1,000,000 | $1,823,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 128,000 | $236,000 | 0.00% |
| CREDIT SUISSE AG/ | 400,000 | $738,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,400,000 | $2,551,000 | 0.00% |